Does Dr. JENEFFER AVALOS TOPETE have financial conflicts of interest?

Dr. JENEFFER AVALOS TOPETE (PA) has received a total of $763 in pharmaceutical and medical device industry funding between 2021 and 2024. This includes $763 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. JENEFFER AVALOS TOPETE?

According to CMS Open Payments data, Dr. JENEFFER AVALOS TOPETE received funding from REGENERON HEALTHCARE SOLUTIONS ($206), GENENTECH USA ($206), and ASTRAZENECA PHARMACEUTICALS ($95).

Does Dr. JENEFFER AVALOS TOPETE receive research grants or speaking fees?

Dr. JENEFFER AVALOS TOPETE has received $763 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. JENEFFER AVALOS TOPETE

PAReal-Time Hydrated

Specialty: Physician Assistant

Practice Location: O FALLON, MO 63368

NPI Number: 1952062689

LIFETIME INDUSTRY VALUE

$763

2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. AVALOS TOPETE is a verified Physician Assistant practitioner based in O FALLON, MO.

Between 2021 and 2024, Dr. AVALOS TOPETE had an overall industry promotional and research financial footprint of $763 as recorded in the federal CMS Open Payments database.

$763 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. AVALOS TOPETE's primary funding source is REGENERON HEALTHCARE SOLUTIONS, which accounts for $206 (representing 27% of overall industry footprint).

Data coverage: 2021 – 2024 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

REGENERON HEALTHCARE SOLUTIONS

Rank 1

$206

27%

GENENTECH USA

Rank 2

$206

27%

ASTRAZENECA PHARMACEUTICALS

Rank 3

$95

12.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2024

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.